IP Protection: Access To Medicine Is Important But So Is Its Continued Improvement
A recent op-ed by Joseph Stiglitz wrongly paints efforts to protect medical intellectual property (IP) as a grand conspiracy by drug companies. In fact, IP rights are a central tool for protecting the global innovation ecosystem and insuring that next generation medications and treatments make it to market.
Editors’ Recommendations
April 1, 2015
How Tech Populism is Undermining Innovation
March 17, 2015